| COMPOSITION: | Each ml contains Prochlorperazine Maleate 12.5 mg in 1 ml ampoule |
| FORMULATION: | INJECTION |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Vomirap contains Prochlorperazine Maleate which works by blocking D2 dopamine receptors in a specific area of the brain called the chemoreceptor trigger zone (CTZ), thus prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery |
| SIDE EFFECTS: | Common side effects are headache, constipation, weakness, tiredness, chills and drowsiness. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
